JPET Assistant Professor of Medicine (Clinician-Educator)

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Journal of Pharmacology And Experimental Therapeutics Fast Forward
First published on August 27, 2003; DOI: 10.1124/jpet.103.053918


0022-3565/03/3071-386-394$20.00
JPET 307:386-394, 2003
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jpet.103.053918v1
307/1/386    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Isaac, S. O.
Right arrow Articles by Berridge, C. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Isaac, S. O.
Right arrow Articles by Berridge, C. W.

BEHAVIORAL PHARMACOLOGY

Wake-Promoting Actions of Dopamine D1 and D2 Receptor Stimulation

Stuart O. Isaac, and Craig W. Berridge

Departments of Psychology (S.O.I., C.W.B.) and Psychiatry (C.W.B.), University of Wisconsin, Madison, Wisconsin

Multiple ascending neurotransmitter systems participate in the regulation of behavioral state. For example, noradrenergic, cholinergic, and serotonergic systems increase EEG and, in some cases, behavioral indices of arousal. The extent to which dopaminergic systems exert a similar activating influence on behavioral state remains unclear. The current studies examined the wake-promoting actions of centrally administered D1 and D2 receptor agonists. In these studies, intracerebroventricular infusions of a D1 (SKF-82958; 2.5 and 25 nmol) or D2 (quinpirole; 40 and 140 nmol)-agonist were made into sleeping animals. The effects of these infusions on electroencephalogram/electromyographic indices of sleep-wake state and behavior were examined. D1 agonist administration dose dependently increased time spent awake and suppressed rapid eye movement and slow-wave sleep in the 2 h immediately after infusion. D1 agonist administration also elicited modest increases in measures of locomotion and time spent grooming and eating. D2 agonist administration had similar wake-promoting actions, accompanied by modest effects on drinking and locomotion. Interestingly, D2 agonist administration also significantly increased time spent chewing on inedible material, an arousal/stress-related behavior. Overall, these results demonstrate that dopamine contributes to the alert waking state via actions of D1 and D2 receptors. Additionally or alternatively, these results further suggest a potential involvement of dopamine receptors in the induction of high-arousal states, including stress.


Received May 10, 2003; accepted June 23, 2003.

Address correspondence to: Dr. Craig W. Berridge, Department of Psychology, University of Wisconsin, 1202 W. Johnson St., Madison, WI 53706. E-mail: berridge{at}wisc.edu




This article has been cited by other articles:


Home page
Proc. Natl. Acad. Sci. USAHome page
R. Andretic, Y.-C. Kim, F. S. Jones, K.-A. Han, and R. J. Greenspan
Drosophila D1 dopamine receptor mediates caffeine-induced arousal
PNAS, December 23, 2008; 105(51): 20392 - 20397.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
G. T. Collins, D. M. Calinski, A. H. Newman, P. Grundt, and J. H. Woods
Food Restriction Alters N'-Propyl-4,5,6,7-tetrahydrobenzothiazole-2,6-diamine dihydrochloride (Pramipexole)-Induced Yawning, Hypothermia, and Locomotor Activity in Rats: Evidence for Sensitization of Dopamine D2 Receptor-Mediated Effects
J. Pharmacol. Exp. Ther., May 1, 2008; 325(2): 691 - 697.
[Abstract] [Full Text] [PDF]


Home page
Journal of Pharmacy PracticeHome page
A. Singh, P. Ghazvini, N. Robertson, A. J. Massey, O. Kirksey, and M. S. Honeywell
Sleep Disturbances in Patients With Psychiatric Illnesses
Journal of Pharmacy Practice, December 1, 2006; 19(6): 369 - 378.
[Abstract] [PDF]


Home page
J. Neurophysiol.Home page
T. E. Fitch, R. N. Sahr, B. J. Eastwood, F. C. Zhou, and C. R. Yang
Dopamine D1/5 Receptor Modulation of Firing Rate and Bidirectional Theta Burst Firing in Medial Septal/Vertical Limb of Diagonal Band Neurons In Vivo
J Neurophysiol, May 1, 2006; 95(5): 2808 - 2820.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
K. Kume, S. Kume, S. K. Park, J. Hirsh, and F. R. Jackson
Dopamine Is a Regulator of Arousal in the Fruit Fly
J. Neurosci., August 10, 2005; 25(32): 7377 - 7384.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2003 by the American Society for Pharmacology and Experimental Therapeutics.